Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 1-2, 2008, Pages 157-162

  Mense, Sarah M ^a   Chhabra, Jaimeet ^a   Bhat, Hari K ^a  

^a Columbia University ^*  (United States)

Author keywords

Catechol estrogens; Cytochrome P450; Estrogen; Estrogen metabolism; Phytoestrogens; Quercetin

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; QUERCETIN;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DRUG MECHANISM; ENZYME REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIOXIDANTS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; BREAST; CELL LINE; CYTOCHROME P-450 CYP1A1; EPITHELIAL CELLS; HUMANS; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RODENTIA;

EID: 44649093884     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.029     Document Type: Article

References (62)

1. Galati G., and O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 37 3 (2004) 287-303
2. Ju Y.H., Allred K.F., Allred C.D., and Helferich W.G. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27 6 (2006) 1292-1299
3. Bhat H.K., Calaf G., Hei T.K., Loya T., and Vadgama J.V. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 100 7 (2003) 3913-3918
4. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., and Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 1766 1 (2006) 63-78
5. Cavalieri E.L., and Rogan E.G. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann. N.Y. Acad. Sci. 1028 (2004) 247-257
6. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., and Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U.S.A. 94 20 (1997) 10937-10942
7. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354 3 (2006) 270-282
8. Clemons M., and Goss P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 344 4 (2001) 276-285
9. Nelson R. Steroidal oestrogens added to list of known human carcinogens. Lancet 360 9350 (2002) 2053
10. Key T., Appleby P., Barnes I., and Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 94 8 (2002) 606-616
11. Liehr J.G., Han X., and Bhat H.K. 32P-postlabelling in studies of hormonal carcinogenesis. IARC Sci. Publ. 124 (1993) 149-155
12. Patel M.M., and Bhat H.K. Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J. Biochem. Mol. Toxicol. 18 1 (2004) 37-42
13. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 203-232
14. Cavalieri E.L., Rogan E.G., and Chakravarti D. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism. Cell Mol. Life Sci. 59 4 (2002) 665-681
15. Badawi A.F., Cavalieri E.L., and Rogan E.G. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 50 9 (2001) 1001-1003
16. Ziegler R.G., Rossi S.C., Fears T.R., Bradlow H.L., Adlercreutz H., Sepkovic D., Kiuru P., Wahala K., Vaught J.B., Donaldson J.L., Falk R.T., Fillmore C.M., Siiteri P.K., Hoover R.N., and Gail M.H. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ. Health Perspect. 105 Suppl. 3 (1997) 607-614
17. LaVallee T.M., Zhan X.H., Herbstritt C.J., Kough E.C., Green S.J., and Pribluda V.S. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 62 13 (2002) 3691-3697
18. Brueggemeier R.W., Bhat A.S., Lovely C.J., Coughenour H.D., Joomprabutra S., Weitzel D.H., Vandre D.D., Yusuf F., and Burak Jr. W.E. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. J. Steroid Biochem. Mol. Biol. 78 2 (2001) 145-156
19. Li J.J., and Li S.A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 46 5 (1987) 1858-1863
20. Liehr J.G., Fang W.F., Sirbasku D.A., and Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24 1 (1986) 353-356
21. Cao K., Stack D.E., Ramanathan R., Gross M.L., Rogan E.G., and Cavalieri E.L. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione. Chem. Res. Toxicol. 11 8 (1998) 909-916
22. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 27 (2000) 67-73
23. Hodek P., Trefil P., and Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139 1 (2002) 1-21
24. Stopper H., Schmitt E., and Kobras K. Genotoxicity of phytoestrogens. Mutat. Res. 574 1-2 (2005) 139-155
25. Sirtori C.R., Arnoldi A., and Johnson S.K. Phytoestrogens: end of a tale?. Ann. Med. 37 6 (2005) 423-438
26. Limer J.L., Parkes A.T., and Speirs V. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro. Int. J. Cancer 119 3 (2006) 515-521
27. Messina M., McCaskill-Stevens W., and Lampe J.W. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J. Natl. Cancer Inst. 98 18 (2006) 1275-1284
28. Peeters P.H., Keinan-Boker L., van der Schouw Y.T., and Grobbee D.E. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res. Treat. 77 2 (2003) 171-183
29. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21 (2001) 381-406
30. Usui T. Pharmaceutical prospects of phytoestrogens. Endocr. J. 53 1 (2006) 7-20
31. Le Corre L., Chalabi N., Delort L., Bignon Y.J., and Bernard-Gallon D.J. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 49 5 (2005) 462-471
32. Nichenametla S.N., Taruscio T.G., Barney D.L., and Exon J.H. A review of the effects and mechanisms of polyphenolics in cancer. Crit. Rev. Food Sci. Nutr. 46 2 (2006) 161-183
33. Ursin G., Bernstein L., and Pike M.C. Breast cancer. Cancer Surv. 19-20 (1994) 241-264
34. Pike M.C., Kolonel L.N., Henderson B.E., Wilkens L.R., Hankin J.H., Feigelson H.S., Wan P.C., Stram D.O., and Nomura A.M. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol. Biomarkers Prev. 11 9 (2002) 795-800
35. Probst-Hensch N.M., Pike M.C., McKean-Cowdin R., Stanczyk F.Z., Kolonel L.N., and Henderson B.E. Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br. J. Cancer 82 11 (2000) 1867-1870
36. Brooks J.D., and Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 94 5 (2005) 461-467
37. Verma A.K., Johnson J.A., Gould M.N., and Tanner M.A. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48 20 (1988) 5754-5758
38. Banerjee S., Bueso-Ramos C., and Aggarwal B.B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62 17 (2002) 4945-4954
39. Bhat K.P., Lantvit D., Christov K., Mehta R.G., Moon R.C., and Pezzuto J.M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61 20 (2001) 7456-7463
40. Fritz W.A., Coward L., Wang J., and Lamartiniere C.A. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19 12 (1998) 2151-2158
41. Lamartiniere C.A., Zhang J.X., and Cotroneo M.S. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am. J. Clin. Nutr. 68 Suppl. 6 (1998) 1400S-1405S
42. Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., and Lamartiniere C.A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17 7 (1996) 1451-1457
43. Hilakivi-Clarke L., Onojafe I., Raygada M., Cho E., Skaar T., Russo I., and Clarke R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 80 11 (1999) 1682-1688
44. Zhu B.T., and Liehr J.G. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 125 1 (1994) 149-158
45. Chang T.K., Chen J., and Lee W.B. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299 3 (2001) 874-882
46. Chun Y.J., Kim M.Y., and Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 262 1 (1999) 20-24
47. Berge G., Ovrebo S., Botnen I.V., Hewer A., Phillips D.H., Haugen A., and Mollerup S. Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br. J. Cancer 91 2 (2004) 333-338
48. Revel A., Raanani H., Younglai E., Xu J., Rogers I., Han R., Savouret J.F., and Casper R.F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 23 4 (2003) 255-261
49. Ciolino H.P., and Yeh G.C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56 4 (1999) 760-767
50. Chen Z.H., Hurh Y.J., Na H.K., Kim J.H., Chun Y.J., Kim D.H., Kang K.S., Cho M.H., and Surh Y.J. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25 10 (2004) 2005-2013
51. Ramadass P., Meerarani P., Toborek M., Robertson L.W., and Hennig B. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol. Sci. 76 1 (2003) 212-219
52. Lu L.J., Cree M., Josyula S., Nagamani M., Grady J.J., and Anderson K.E. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res. 60 5 (2000) 1299-1305
53. Wood C.E., Register T.C., and Cline J.M. Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogenesis (2006)
54. Xu X., Duncan A.M., Wangen K.E., and Kurzer M.S. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9 8 (2000) 781-786
55. Xu X., Duncan A.M., Merz B.E., and Kurzer M.S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol. Biomarkers Prev. 7 12 (1998) 1101-1108
56. Bhat H.K., and Epelboym I. Suppression of calbindin D28K in estrogen-induced hamster renal tumors. J. Steroid Biochem. Mol. Biol. 92 5 (2004) 391-398
57. Bhat H.K., and Epelboym I. Quantitative analysis of total mitochondrial DNA: competitive polymerase chain reaction versus real-time polymerase chain reaction. J. Biochem. Mol. Toxicol. 18 4 (2004) 180-186
58. Bhat H., Brad T.E., and Liehr J.G. Differential estrogen regulation of c-fos in hamster kidney and kidney tumor cells: receptor mediation verses metabolic activation. Int. J. Oncol. 7 (1995) 527-534
59. Wood C.E., Register T.C., Franke A.A., Anthony M.S., and Cline J.M. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res. 66 2 (2006) 1241-1249
60. Duncan A.M., Underhill K.E., Xu X., Lavalleur J., Phipps W.R., and Kurzer M.S. Modest hormonal effects of soy isoflavones in postmenopausal women. J. Clin. Endocrinol. Metab. 84 10 (1999) 3479-3484
61. Lu L.J., Anderson K.E., Grady J.J., Kohen F., and Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 60 15 (2000) 4112-4121
62. Wu A.H., Stanczyk F.Z., Seow A., Lee H.P., and Yu M.C. Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol. Biomarkers Prev. 11 9 (2002) 844-851